Surface Oncology, Inc. (SURF)
(Delayed Data from NSDQ)
$4.87 USD
+0.02 (0.41%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.84 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[SURF]
Reports for Purchase
Showing records 1 - 20 ( 51 total )
Industry: Medical - Products
Dropping Coverage of SURF Following Acquisition by CHRS
Provider: Wedbush Securities Inc.
Analyst: Research Department
Industry: Medical - Products
Q2 Financials; CHRS Merger on Track for Sep 2023
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Products
Surface to Be Acquired by Coherus; Downgrade to Neutral With a $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Products
SURF to be Acquired by CHRS; Downgrading to NEUTRAL; PT to $1.15
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Products
SRF388 Phase 2 Readouts Imminent; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Products
1Q23 Financials; SRF388 Clinical Updates on Track for 2Q23
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Products
Eyes on SRF388 Update in NSCLC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Products
Industry: Medical - Products
Q4/FY22 Financials; SRF388 (IL-27 mAb) data updates anticipated 1H23
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Products
Industry: Medical - Products
SRF388 Moves Forward in NSCLC; SRF617 Development Shelved; Lower PT to $6.00; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Products
Q3 Financials; Monotherapy SRF388 Responses in sqNSCLC; SRF617 Paused
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Products
Development Programs Progressing; SRF617 Clinical Update Expected in 2H22; Lower $8.50 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Products
Industry: Medical - Products
Q2 Financials; SRF617 Data Update Later in 2022, SRF388 HCC Update in 1H:23
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Data Readouts on the Horizon; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S